A r t i c l e s
Astroglial cells are the most abundant cell type in the human brain and spinal cord and are now understood to be as important as neurons for brain function 1,2 . During development, astroglial progenitors are specified after neurogenesis, although their identity is not well defined owing to lack of reliable markers 3, 4 . Astroglial progenitors differentiate to immature astrocytes, which are essential for the formation of functional synapses 5, 6 . In the adult brain, mature astrocytes insulate synapses and remove excess transmitters, such as glutamate, released during neural excitation, thus preventing excitotoxicity 7 . Astrocytes are crucial for maintaining a homeostatic environment for the healthy brain by supporting neurovascular coupling at the blood-brain barrier, regulating blood flow 8 and supplying energy metabolites throughout the brain 9 . Abnormalities in astroglial cells are implicated in a number of human pathologies, including astrocytomas, epilepsy 10 , Alexander disease 11 and neurodegenerative diseases 12, 13 . Thus, understanding how to regulate the generation, maintenance and functions of human astroglial cells will likely benefit the treatment of a range of neurological injuries and diseases.
Astrocytes are heterogeneous in many respects, including morphology, growth rates 14 , gene expression profiles 15, 16 , electrophysiological properties 17 , gap junction coupling and calcium wave propagation dynamics 18, 19 . However, how these various astroglial phenotypes are gained is largely unknown. In the mouse and chick spinal cord, homeodomain and helix-loop-helix (HLH) transcription factors are expressed in progenitors of specific dorsal-ventral domains, and genetic alterations of these factors shift the gene expression pattern of astrocytes generated from these domains [20] [21] [22] . This suggests that astroglial diversity may be determined through regional patterning (specification of regional identities) of progenitor cells. However, it remains unknown whether astroglial subtypes may be generated by simply patterning neural stem or progenitor cells, especially human stem cells.
In the present study, we describe a chemically defined differentiation system for efficient generation of immature astrocytes from hPSCs, including embryonic (hESCs) and induced pluripotent stem cells (iPSCs). HPSCs were first differentiated to neuroepithelial cells and specified to regional progenitors. They were then expanded as free-floating clusters or 'astrospheres' in the presence of growth factors, with periodic dissociation into single cells to promote gliogenesis. Astroglial differentiation from human neural stem cells or fetal tissues often requires serum, and the capacity to expand is limited. In contrast, the present technology allows generation of a nearly pure population of astroglial progenitors in a chemically defined system, which can be expanded to large quantities. Furthermore, the resultant cell population is free of immune cells such as microglia, and regionally and functionally specialized astroglial subtypes can be readily generated. We apply this approach to three different hPSC lines and show that it yields progenitors that can expand in culture for a long time, producing an estimated 2.8 × 10 12 immature astrocytes at 6 months from one hPSC cell. Notably, we find that regionally and functionally distinct human astroglial subtypes are induced by patterning neuroepithelial cells at an early stage, and that they maintain their identities after transplantation into ectopic mouse brain regions, providing a possible cellular source for regenerative medicine.
RESULTS

Differentiation to astroglia follows developmental principles
Astroglial cells appear after neurons during vertebrate development. We hypothesized that hPSC-derived neural progenitors, after specification of transplantable astroglial subtypes from human pluripotent stem cells Human pluripotent stem cells (hPSCs) have been differentiated efficiently to neuronal cell types. However, directed differentiation of hPSCs to astrocytes and astroglial subtypes remains elusive. In this study, hPSCs were directed to nearly uniform populations of immature astrocytes (>90% S100b + and GFAP + ) in large quantities. The immature human astrocytes exhibit similar gene expression patterns as primary astrocytes, display functional properties such as glutamate uptake and promotion of synaptogenesis, and become mature astrocytes by forming connections with blood vessels after transplantation into the mouse brain. Furthermore, hPSC-derived neuroepithelia, patterned to rostral-caudal and dorsal-ventral identities with the same morphogens used for neuronal subtype specification, generate immature astrocytes that express distinct homeodomain transcription factors and display phenotypic differences of different astroglial subtypes. These human astroglial progenitors and immature astrocytes will be useful for studying astrocytes in brain development and function, understanding the roles of astrocytes in disease processes and developing novel treatments for neurological disorders.
A r t i c l e s temporal expansion, become gliogenic and generate astroglia under conditions that facilitate glial differentiation (Fig. 1a) . HPSCs were directed to neuroepithelial cells, followed by differentiation to neural progenitors from days 10 to 21 in the presence of either the posterior patterning molecule retinoic acid (0.5 µM), or the anterior patterning morphogen fibroblast growth factor 8 (FGF8, 50 ng/ml) 23, 24 to examine whether early specification leads to divergent astroglial subtypes (see below). Differentiation of day 30 retinoic acid-treated progenitors from the H9 hESC line showed that a small population of cells (7.7% ± 1.5) were S100β + and hardly any cells (<0.1%) were GFAP + , the two common astroglial markers. Most other cells were shaped like columnar epithelial cells, indicative of progenitor identity, whereas some exhibited neuronal phenotypes and were positive for the neuron-specific marker βIII-tubulin (4.4% ± 0.8), which decreased over time. At increasing time periods, the number of S100β + cells continued to increase, and displayed the typical stellate morphology of astroglia (Fig. 1b,c) . Similarly, GFAP-expressing cells began to appear after 8 weeks, and the percentages increased over time (Fig. 1b,c) . The GFAP + cells always co-labeled with S100β. A similar progression of astroglial marker expression was observed in cells that were specified with FGF8, but considerably slower at certain time points (Fig. 1c) . Aldh1L1, a recently identified marker for the astroglial lineage 25 , but not NG2, a proteoglycan expressed by NG2 cells 26 , was also detected in GFAP + cells (Fig. 1d) . Western blotting analysis of day 180 immature astrocytes demonstrated the expression of GFAP and the astrocyte-specific glutamate transporter GLT-1 (Fig. 1e) . These results further confirmed their astroglial identity. Leukemia inhibitory factor (LIF) had a similar effect as ciliary neurotrophic factor (CNTF) in increasing the proportion of GFAP + cells after treatment of the day 180 progenitors for 6 d (Supplementary Fig. 1a) .
To identify progenitors during astroglial differentiation, we examined putative glial progenitor markers, including A2B5, CD44 (ref. 27 ) and NFIA 28 . A2B5 was expressed in a subset of S100β + cells at days 30 and 90 (9.8% ± 3.2 and 8.7% ± 2.1, respectively), and the percentage decreased as cells became GFAP + . CD44, however, was not observed until day 60, and by day 90, 79.5 ± 1.9% of S100β + cells expressed CD44 (Fig. 1f) . NFIA, which was completely absent in PAX6 + neuroepithelial cells at day 11, began to be expressed by day 30 as cells downregulated PAX6. Day 180 astroglial cells all expressed high levels of NFIA (Fig. 1g) . Thus, astroglial progenitors or immature astrocytes can be identified by expression of NFIA-S100β at 4-8 weeks after hPSC differentiation, and more mature astrocytes can be marked additionally by CD44-GFAP after 8-12 weeks of differentiation. This expression pattern is remarkably similar to that of in vivo human development 29, 30 . 
A r t i c l e s
Quantitative reverse transcription (qRT)-PCR analysis indicated that the hPSC-derived day 210 astroglia expressed high levels of additional astroglial genes, including NF1X, CHL1, GLAST, GLT1 and aquaporin 4 ( Supplementary Fig. 1c ). Taken together, these results not only confirmed the astroglial identity but also suggested functional attributes of the hPSC-derived astroglia. The hPSC-derived astroglial progenitors were expanded continuously for at least 8 months and survived freeze-thaw cycles. BrdU pulse-labeling for 10 h in day-60 progenitors revealed a higher percentage of cells undergoing DNA synthesis, a correlate of cellular proliferation, in FGF8-specified progenitors (74.2% ± 2.0, n = 6) compared to retinoic acid-specified progenitors (50.6% ± 6.1) (Fig. 1h) . At 6 months, the extent of BrdU labeling decreased, the two groups exhibited a similar proliferation rate, and removal of growth factors inhibited DNA synthesis (Fig. 1h) . In the presence of EGF and FGF2, the retinoic acid-specified astroglial progenitors maximally expanded at a rate of 7.6 ± 1.2 times every 6 d for 4-5 months when seeded at 24,000 cells/cm 2 . Although hESCs and iPSCs exhibit slightly different efficiency in neuroepithelial cell generation 31 , differentiation of neuroepithelial cells and expansion of astroglial progenitors from these various hPSC lines (H9, H7, (IMR90)-4) were similarly efficient. If one hPSC is differentiated to neuroepithelial cells, converted to glial progenitors and then expanded in suspension, an estimated 2.8 × 10 12 immature astrocytes can be generated in 6 months, taking into account any cell loss during the procedure. Therefore, this method allows generation of large quantities of astroglia.
Regionally specified neuroepithelia generate astroglial subtypes Like neurons, astrocytes in different regions of the central nervous system (CNS) exhibit different phenotypes. We hypothesized that regionally distinct astroglia may be specified from hPSCs in the same way as for neuronal cell types through patterning of neuroepithelial cells and subsequent differentiation (Fig. 2a) . At day 30 of differentiation from H9 hESCs, nearly all of the cells patterned with retinoic acid during days 10-21 expressed the hindbrain/spinal cord-specific transcription factor HOXB4 (98.6% ± 0.7, n = 5) and very few expressed the midforebrain marker OTX2 (3.1% ± 0.8). The FGF8-treated cells, similar to those not treated with FGF8 (ref. 32) , expressed OTX2 (95.4% ± 3.0) and none expressed HOXB4. This expression pattern of homeodomain transcription factors persisted as cells began to express astroglial markers S100β and GFAP (Fig. 2b-d and Supplementary  Fig. 2a ), but with a slight decrease of OTX2 in GFAP + astrocytes. A similar expression pattern of homeodomain transcription factors was observed in primary astrocytes isolated from the mouse embryonic brain and spinal cord (Supplementary Fig. 2c ), and in astrocytes specified from iPSCs ( Supplementary Fig. 3) . qRT-PCR analysis confirmed differential expression of additional homeodomain genes and functional genes in the anterior and posterior immature astrocytes (Supplementary Fig. 2b ), signaling potential functional diversities.
To determine whether astroglia with a dorsal-ventral distinction can also be specified, neuroepithelial cells were treated with or without the ventralizing factor sonic hedgehog (SHH, 500 ng/ml). In the absence of morphogens, hESC-derived neural progenitors exhibit a dorsal telencephalic phenotype 33 ; none of the astroglial progenitors expressed the ventral marker NKX2.1 (Fig. 2e,f) . In contrast, the majority of astroglial progenitors (day 30) differentiated from the SHH-treated neuroepithelial cells were labeled for NKX2.1, though NKX2.1 was noticeably decreased upon S100β expression (Fig. 2f) . Regional marker expression was confirmed in subsets of GFAP + astrocytes in P1 mouse brain and spinal cord sections ( Supplementary  Fig. 2d) . Together, our results indicate that region-specific astroglia can be specified from hPSCs in the same way as for region-specific neuronal types. The same trend of astroglial differentiation and regional patterning was observed with the H7 hESC line and the (IMR90)-4 iPSC line (Supplementary Fig. 3a,b) .
HPSC-derived immature astrocytes are functional
In contrast to neurons, astroglia are described as passive cells because they cannot generate action potentials and their voltage-gated currents decrease during maturation 34 both retinoic acid-specified (n = 18) and FGF8-specified astroglia (n = 10, expanded for 120 d from line H9 and treated with CNTF for 7 d) displayed a voltage-dependent initial rapid outward current that was inactivated within 100 ms and a lower sustained current, and never displayed action potentials in current clamp. This passive electrophysiological property resembles that observed in immature primary mouse astrocytes 34 . To determine whether neuronal signaling promotes astroglial maturation, 120-d red fluorescent-labeled astroglia were cultured either with or without hESC-derived neurons (day 28) for 2 weeks (Fig. 3a) . Co-cultured astroglia displayed a change in morphology and a significantly decreased transient outward current (n = 10 with and without neurons), suggesting maturation of astroglial cells in vitro.
One critical function of astrocytes is signaling and buffering of neurotransmitters released during neuronal excitation. To determine whether hESC-derived immature astrocytes contain functional glutamate receptors, we applied the glutamate receptor agonist AMPA or l-glutamate (100 µM) in the absence or presence of CNQX and AP5 (20 µM). An inward current was activated upon addition of AMPA, which was completely blocked in the presence of CNQX and AP5 (retinoic acid-specified, n = 5; FGF8-specified, n = 5) (Fig. 3b) . In contrast, the l-glutamate response was partially blocked. l-glutamate induced a large inward current in all cells tested (retinoic acid-specified, n = 8; FGF8-specified, n = 8). 100 µM of d,l-aspartate produced a similar inward current (not shown). When the GLT-1-specific inhibitor dihydrokainate (DHK, 100 µM) was applied to the same cells for 1 min before l-glutamate administration, the inward current was substantially smaller, suggesting that glutamate-induced inward currents depend on the function of glutamate transporters. Addition of the general glutamate transporter blocker l-serine-O-sulfate (SOS, 100 µM) further decreased the current (Fig. 3b) . No significant differences in induced currents were observed between the two subtypes of immature astrocytes owing to the high variability of peak currents between cells. Furthermore, hESC-derived immature anterior astrocytes were competent to take up glutamate from media over time at a higher rate than that of HEK293 cells, but not in the presence of the glutamate transporter inhibitor PDC or in sodium-free media (n = 3) (Fig. 3c) . Together, these results indicate that the hESC-differentiated immature astrocytes possessed functional glutamate receptors and transporters.
Propagation of calcium waves across astrocytes, activated by various stimuli, is important in glial and neuron-glial communication 35 , and calcium wave dynamics are different in regionally distinct astrocytes 18, 19 . Fluorescent intensity of Fluo-4 loaded hESC (line H9)-derived 6-month immature astrocytes was observed during mechanical stimulation of a small area <20 µm. In all cells tested, stimulation induced an intra-and intercellular calcium wave in the vicinity, which traveled outward to adjacent cells (Fig. 3d and  Supplementary Movie 1) . Wave propagation was found to be dependent upon extracellular ATP signaling, because it was reduced by the presence of apyrase, an ATP hydrolytic enzyme, but not of the gap junction blocker carbenoxolone (Supplementary Fig. 4) . The distance traveled by the calcium waves was different between retinoic acid-and FGF8-specified astroglia (Fig. 3d) . Application of the InsP3 receptor blocker 2-APB 36 reduced the calcium wave distance for both retinoic acid-and FGF8-astroglial groups (Fig. 3d) . Astroglia generated without FGF8 treatment, which also display anterior characteristics (Supplementary Fig. 2b) , propagated waves in similar A r t i c l e s distances as that of the FGF8-specified astroglia (30 s; 106.5 ± 2.3 µm, P = 0.1369) and significantly different from that of retinoic acidspecified astroglia (P < 0.001) (data not shown). Thus, similar to astrocytes in vivo, hESC-derived immature astrocytes are competent for network communication.
Another function of astrocytes, especially immature astrocytes, is promotion of synaptogenesis 5, 6, 37 . To determine whether hPSCderived immature astrocytes possess the same function, we cultured hESC-derived (day 21) neuronal progenitors alone, or in direct contact with immature astrocytes. The density of synapsin 1 + puncta along the neurites was significantly (P = 0.0119) increased in neurons after 3 weeks of direct co-culture on hESC-derived (anterior) immature astrocytes compared to those without (Fig. 3e) , suggesting the ability of hPSC-astrocytes to modulate synaptogenesis.
Regional and astroglial identity is retained in vivo
To determine whether hPSC-differentiated astroglia maintain their identity in vivo, we transplanted dissociated immature astrocytes, treated for 1 week with CNTF after 6 months of differentiation from line H9, into the lateral ventricles of neonatal mice (Fig. 4a) . Thirty (n = 2 for retinoic acid group, n = 2 for FGF8 group) and 100 d (n = 3 for retinoic acid group, n = 4 for FGF8 group) after transplantation, grafted human cells, identified by human nuclear protein (hNUC), were observed as clusters adjacent to the lateral ventricles and as a stream of migrating cells in the corpus callosum. In every brain section examined, all of the transplanted hNUC + cells expressed a high level of GFAP (Fig. 4b,c) . Cells that entered the corpus callosum were elongated in parallel with axons. Astroglial progenitor clusters (after 6 months without CNTF treatment, H9 line) transplanted directly into the adult mouse hippocampus also survived after engraftment (2 weeks; n = 4 for retinoic acid group and n = 2 for FGF8 group; 6 weeks; n = 4 for both groups) and continued to express GFAP (Fig. 4d,e) , but not the neuronal marker βIII-tubulin + , even in the neurogenic dentate gyrus (Fig. 4f) . This result indicated that the hESC-derived astroglial progenitors or immature astrocytes retained their identity in vivo.
Immunostaining of the ventricle-transplanted cells for homeodomain transcription factors showed that all hNUC + cells in clusters and those migrating through the corpus callosum were positive for HOXB4 (day 30 = 70/70, day 100 = 65/65), but not for OTX2, and no hNUC-/GFAP + endogenous astrocytes in this region co-labeled with HOXB4 for the retinoic acid-specified astroglial group (Fig. 4c) . In the brains transplanted with FGF8-specified immature astrocytes, all hNUC + cells were positive for OTX2 (day 100 = 52/52), but not HOXB4, and endogenous OTX2 + astrocytes could be observed (Fig. 4c) . Therefore, the regional specificity of astrocytes, which is acquired during early in vitro differentiation, is retained and not altered by the ectopic in vivo brain environment.
To determine whether in vitro-generated human astroglia can mature and integrate into the mouse brain, we examined whether they were in close apposition to blood vessels, a sign of contribution or signaling of astrocytes to the blood-brain barrier 38 . As blood-brain barrier formation requires coordinated development of blood vessels and astrocytes, we transplanted hESC-derived neural progenitors (day 21) to the ventricles of neonatal mouse brain and looked for direct connections of human GFAP + fibers to vessels. Few GFAP + cells were generated from grafted hESC-derived neuroepithelial cells within 3 months, as previously described 39 . However, 6 months after transplantation, a number of GFAP + /hNUC + cells projected elongated fibers to blood vessels, with end feet directly contacting the vessels (Fig. 4g,h and Supplementary Movie 2). In contrast, endogenous mouse astrocytes are smaller, and the somas directly surround vessels. This distinction is similar to phenomena observed in adult human and rodent tissues 40 . These results indicate that the hPSC-derived astroglia can mature and participate in blood-brain barrier structure formation and that they exhibit some unique features of human astrocytes even in the mouse brain.
DISCUSSION
We have developed a chemically defined system for efficiently directing hPSC-derived neural progenitors to a nearly uniform population of astroglial progenitors and immature astrocytes through long-term expansion of dissociated progenitors in the presence of FGF2 and EGF. The in vitro-produced human immature astrocytes possess functional hallmarks of primary astrocytes, including responses to glutamate, propagation of calcium waves, promotion of synaptogenesis and participation in blood-brain barrier formation. Notably, we provide evidence that regionally and functionally diversified astroglial subtypes can be efficiently specified through patterning of early neuroepithelial cells with the same set of morphogens used for generating neuronal subtypes. Both astroglial identity and regional characteristics are maintained after long-term in vitro expansion and after transplantation into the mouse brain. Such human immature astrocytes, which can be generated in large quantities from an almost unlimited source of stem cells, should be useful in basic research, drug discovery and regenerative biology. The regional and functional heterogeneity of astroglia has been well recognized 41 . However, it remains unclear whether this heterogeneity arises from intrinsic developmental programs or exclusively from adaptation to environmental cues. We have shown here that the regional identity of neuroepithelial cells, specified by a single morphogen, is maintained during subsequent differentiation. Comparisons of astroglial subtypes revealed differential onset of S100β and GFAP expression, cellular proliferation, gene expression and calcium wave propagation. Thus, the regional identity of astroglial cells is at least partially determined during neuroepithelial patterning, as has been previously postulated 22, 42, 43 , and we propose that combinatorial morphogen patterning of neuroepithelial cells may lead to the generation of increasingly diversified astroglial subtypes (Fig. 5) . This hypothesis suggests that regionalized neural progenitors migrate to target brain regions and then give rise to neurons before becoming astroglial cells, which may explain why we do not observe clear differential migration patterns of regionalized astroglia. Nevertheless, astroglial progenitors and immature astrocytes tend to target the white matter.
Functional properties of astroglia, particularly those of regional astroglia, are generally considered the outcome of responses to local brain environments 44 . Given the minimal presence of neurons and absence of immune cells in our culture system, our data suggest that at least some functions, described here, are intrinsic when astroglia are born. It should be pointed out that the astroglial cells in our culture system correspond to those at an early stage of the developing human brain. In the developed brain, astrocytes may well acquire additional mature functions, especially in response to local cues 45 . Furthermore, both the astroglial identity and regional characteristics are maintained after long-term in vitro expansion of their progenitors and after transplantation into the mouse brain environment. The intimate connections of hPSC-derived astrocytes with blood vessels suggest functional ability in vivo, though further work is needed to determine whether these cells can affect brain signaling or behavior.
Astrocytes in the human nervous system appear more complex than those in lower mammals 40 . Our present findings indicate that differentiation of human ESCs to a robust population of GFAP + astroglia (which takes at least 12 weeks) is substantially slower than that of mouse ESCs (which takes ~2 weeks), corresponding to astroglial development in the human brain. This prolonged development explains why hPSC-derived astroglial cells in vitro exhibit characteristics of immature rodent astrocytes in vivo, including the presence of voltage-gated currents 34 and induction of neuronal maturation 37 . Nevertheless, the immature astrocytes appear to mature over time when co-cultured with neurons or transplanted into the brain to participate in blood-brain barrier formation. Our ability to derive and expand an enriched population of astroglial progenitors, as well as to differentiate them to immature astrocytes, will facilitate studies of the role of human astrocytes in the normal and diseased brain and of transplantation therapies for neurological diseases such as amyotrophic lateral sclerosis, as suggested previously with mouse primary astrocytes 46 . In addition, astroglial cells derived from patient-specific iPSCs offer yet another approach for therapeutic discovery.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturebiotechnology/.
Note: Supplementary information is available on the Nature Biotechnology website.
